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Epidemiology of traveler's diarrhea
Abstract
Among travelers from developed countries who visit developing countries, >60% may experience
traveler's diarrhea, accounting for 40,000 travelers daily or >15 million travelers annually. Traveler's
diarrhea is often accompanied by other symptoms, most often abdominal cramps. Although the
spontaneous cure occurs after a mean of 4 days, a few patients have symptoms for weeks, and it is
increasingly noted that some patients may later develop irritable bowel syndrome. Traveler's diarrhea is
life threatening only exceptionally, but it frequently it leads to incapacitation. Both host factors (e.g.,
age, behavior, nationality, and genetic factors) and environmental factors (primarily the selected
destination and hotel) play an important role in risk for traveler's diarrhea.
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Epidemiology of Traveler’s Diarrhea
Robert Steffen
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Collaborating Center for Travelers’ Health, Zurich, Switzerland
Among travelers from developed countries who visit developing countries, 160% may experience traveler’s
diarrhea, accounting for 40,000 travelers daily or 115 million travelers annually. Traveler’s diarrhea is often
accompanied by other symptoms, most often abdominal cramps. Although the spontaneous cure occurs after a
mean of 4 days, a few patients have symptoms for weeks, and it is increasingly noted that some patients may
later develop irritable bowel syndrome. Traveler’s diarrhea is life threatening only exceptionally, but it frequently
it leads to incapacitation. Both host factors (e.g., age, behavior, nationality, and genetic factors) and environmental
factors (primarily the selected destination and hotel) play an important role in risk for traveler’s diarrhea.
Diarrhea is a frequent health problem in developing
countries. Most important, it still is a very relevant
cause of death, mainly among infants and children;
according to a World Health Organization fact sheet,
2.1 million people died of diarrheal diseases in 2000
[1]. Similar to these children, travelers visiting desti-
nations in developing countries are nonimmune with
respect to the many gastrointestinal pathogens that are
endemic to those countries; because the travelers have
never been exposed to the pathogens, they have been
unable to gradually develop immunity.
If we estimate conservatively that 50 million travelers
will visit developing countries every year (World Tour-
ism Organization, unpublished data) and that 30%–
40% of those travelers will experience traveler’s diar-
rhea, then we can conclude that 15–20 million travelers
will experience traveler’s diarrhea annually (i.e., 40,000
travelers daily).
Classic traveler’s diarrhea is usually defined as3 un-
formed bowel movements occurring within 24 h and
accompanied by other symptoms, most often cramps,
nausea, fever, blood admixed to the stools, and vomiting
[2–5]. Fecal urgency is usually also associated with trav-
eler’s diarrhea. Moderate traveler’s diarrhea is defined as
1 or 2 unformed bowel movements occurring every 24
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h with additional symptoms or as 3 unformed bowel
movements without additional symptoms. Mild travel-
er’s diarrhea is defined as 1 or 2 unformed bowel move-
ments without any additional symptoms [2].
Dysentery in travelers is usually defined as invasive
traveler’s diarrhea resulting in fever and/or accompa-
nied by blood admixed to the stools. In a recent study,
the rates of dysentery were 7% in Goa, India, 5% in
Mombasa, Kenya, and 2% in Jamaica and Fortaleza,
Brazil [3]. Rates 110% have previously been noted in
North Africa and Turkey (figure 1).
RATES AND CHRONOLOGY
Data from different parts of the world are shown in
table 1; data are lacking for many destinations. Business
travelers and military populations, as well as tourists,
are affected by traveler’s diarrhea [8, 9]. In outbreaks
in hotels or on cruise ships, a single pathogen can often
be identified [10]. Frequently, data cannot be compared
with precision, because some are defined in terms of
attack rates per stay abroad, whereas others are defined
in terms of incidence rates per 1 or 2 weeks of stay.
Nevertheless, an order of magnitude of risk for regions
emerges. As shown in figure 1, developing countries
are high-risk regions, with rates of traveler’s diarrhea
of 20%–90% per each 2-week stay. In contrast, visitors
to low-risk areas experience traveler’s diarrhea at rates
of !8% per each 2-week stay. Destinations with inci-
dence rates 18% but !20% are considered to be inter-
mediate-risk regions.
Figure 1. Worldwide risk zones for travelers’ diarrhea (TD) and proportion of cases of dysenteric TD (i.e., TD resulting in fever and/or accompanied by blood admixed to the stools) associated with
a stay of 2 weeks abroad [6].
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Table 1. Observational studies of attack/incidence rates of
travelers’ diarrhea (TD) among civilian travelers originating from
developed countries at various destinations.
Continent, region or country Year
Rate of
TD, %
No. of
travelers
at risk
Africa
East Africa 1975–1981 30 2646
West Africa 1975–1977 39 505
Tunisia 1975–1977 48 988
Kenya 1977–1978 43 42
Morocco 1977 54 24
Tunisia 1979–1980 20 706
Egypt 1979–1980 20 706
Morocco 1979–1980 38 706
Egypt (Nile cruises) 1989–1991 10–90 1500
Egypt 1992 59 257
Tunisia 1992 40 2695
Morocco 1992 30 1639
Algeria 1992 13 728
West Africa 1995 27 141
East Africa 1995 26 383
West Africa 1991–1992 25 53
Kenya 1997–1998 55 15,181
Tunisia 1998 34 397
Morocco 1998 25 263
North and South America
Mexico 1957 33 1000
Mexico 1975 40 55
Mexico 1975 29 133
Mexico 1976 49 121
Mexico (from Panama) 1979 36 64
Mexico 1975–1981 31 1104
Brazil 1975–1981 33 1305
South America (various) 1975–1981 36 420
United States/Canada 1975–1977 4a 1379
Mexico (Cuba) 1986–1987 34 227
Mexico 1992 45 84
South America 1995 33 282
Central America 1995 33 120
Honduras 1980 54 22
Honduras 1984 100 22
Jamaica 1996–1997 24 30,369
Brazil 1997 14 6050
Asia
Sri Lanka/ Maldives 1975–1981 35 1371
Thailand 1975–1981 22 1838
Far East (various) 1975–1981 31 2470
Thailand 1984 24 33
Thailand 1981 57 35
Middle East 1991–1992 48 30
Southeast Asia 1995 19 487
South Asia 1995 39 250
India (Goa) 1997–1998 54 15,631
Turkey 1998 27 617
(continued)
Table 1. (Continued.)
Continent, region or country Year
Rate of
TD, %
No. of
travelers
at risk
Europe
Northern Europe 1953 35 26
Southern Europe 1953 67 127
Northern Europe 1970 4 1551
Western Europe 1970 6 1465
Southern Europe 1970 12 1498
Spain 1979–1980 !15 1685
Canary Islands 1981 20 572
Rhodes 1981 13 987
Southern Europe 1984 15 720
Portugal 1998 9 560
Spain 1998 7 906
Greece 1998 7 1398
Cyprus 1998 8 688
Italy 1998 4 113
NOTE. Incidence was calculated for a 1-week stay [7].
a Control.
Seasonality has only a limited relevance to rates of traveler’s
diarrhea: among British tourists in Monastir, Tunisia, the rates
of traveler’s diarrhea varied from 16%–18% in May–July to
20%–23% in August–October [11]. Similarly, rates of total and
classic traveler’s diarrhea were highest from June to October
in Jamaica and elsewhere [2, 12].
When rates are compared over time, it becomes obvious that
there has been a dramatic reduction in traveler’s diarrhea rates
in southern Europe [13]. It also appears that Tunisia and Ja-
maica have been able to reduce the risk of illness through the
systematic efforts of their authorities, mainly the ministries of
health and tourism [14, 15]. In contrast, over the past decades,
hardly any risk reduction has been observed at most other
destinations, when travelers were investigated with identical
questionnaires by our group.
RISK GROUPS
Even at a single destination, there are highly significant differ-
ences in traveler’s diarrhea incidence rates for different risk
groups. The most important factor likely is the selection of a
hotel. As demonstrated in Jamaica, the incidence rates of trav-
eler’s diarrhea for 18 hotels visited by at least 40 clients for 1
week varied from 0% to 33% ( ) [2]. Experts realizeP ! .001
that the incidence rates of traveler’s diarrhea mirror the hy-
gienic conditions of the places visited [14]. As expected, the
duration of exposure is also relevant [16]. It has already been
demonstrated in previous studies that 5-star hotels tend to have
a slightly higher traveler’s diarrhea incidence rate, compared
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Table 2. Incapacitation due to travelers’ diarrhea (TD) in 3
countries.
Variable
Country
Jamaica India Kenya
Proportion of incapacitated subjects, %
Patients only 31.0 45.7 29.4
All travelers 8.3 29.9 20.9
Duration of incapacitation due to any TD, h 11.6 21.2 15.6
Effect in all travelers, %a 8.1 34.6 32.7
NOTE. “Incapacitation” is defined as the inability to pursue planned ac-
tivities [2, 3].
a Includes incapacitation, consultation of a health care professional, and use
of (exotic) medication.
with many 3- or 4-star hotels. This finding is plausible, con-
sidering that food items are more frequently prepared by hand
in higher-end hotels. The type of travel also plays a role: beach
vacations in a resort are associated with lower attack rates
(28%), tours are associated with slightly higher rates (31% for
group tours and 32% for individual tours), and adventure tours
are associated with the highest rates (34%; ) [4]. “All-Pp .04
inclusive” tours tend to be associated with higher attack rates,
which can hypothetically be explained by greater consumption
of alcoholic beverages by travelers on such tours [17].
Second, the origin of traveler is the most relevant host factor.
It has long been known that persons from developing countries
have a very low incidence rate of traveler’s diarrhea (2%–8%)
when visiting other developing countries; this phenomenon has
been demonstrated in delegates to conventions and in students
and military populations [7, 18]. Similarly, various studies have
demonstrated that travelers who recently visited the tropics
have a diminished incidence rate of traveler’s diarrhea, probably
as a result of some developed immunity [3].
Various studies have demonstrated that younger age is a risk
factor for traveler’s diarrhea. Infants, toddlers, and young adults
15–30 years old are particularly prone to developing travel-
er’s diarrhea [19–21]. We could imagine that small children are
at particularly high risk for traveler’s diarrhea, because their
fingers indiscriminately touch floors and other contaminated
things before being licked, whereas, in young adults, a greater
appetite may result in consumption of a larger inoculum of
pathogens. In most studies, no significant, or at least no clin-
ically relevant, difference in traveler’s diarrhea incidence rates
has been observed according to sex [3, 16]. The more adven-
turous travel style of young adults is not the only explanation
for the higher risk, because the significant difference is dem-
onstrated even when the population is stratified by hotel and
when only travelers on all-inclusive tours, who do not consume
any meals outside the hotel, are analyzed.
Recently, it has been demonstrated that there is also a genetic
susceptibility to traveler’s diarrhea. Diarrhea due to infection
with enteroaggregative Escherichia coli occurs significantly more
often in individuals with the AA genotype251 (OR, 209; 95%
CI, 28–1525) than in individuals with the T genotype (OR, 14;
95% CI, 2–105) or even the TT genotype (OR, 1) [22]. It is
unknown whether a higher incidence rate of traveler’s diarrhea
among British travelers is associated with genetic differences or
different dietary habits [23]. In addition, a lack of gastric acidity,
either as a result of surgery or in association with the use of
such medications as omeprazole or magnesium and aluminium
hydroxide (e.g., Maalox; Novartis), has been identified as a risk
factor for traveler’s diarrhea [24].
Lack of avoidance of potentially contaminated food and bev-
erages may play a role, as discussed elsewhere in this supplement
[25]. Additional behavioral risk factors may be bathing in seawater
[26] or eating meals purchased in cafeterias or from street vendors
[21, 27, 28]. The consumption of unpasteurized milk also resulted
in excessive risk (OR, 6.2); similarly, Mexican sauces have often
been identified as being contaminated [29]. With regard to alcohol
consumption, drinking beer resulted in a significant higher trav-
eler’s diarrhea rate [3], whereas there is indication that drinking
wine may have some protective effect [30, 31].
IMPACT
Traveler’s diarrhea usually is not a severe illness, but it may
lead to extreme frustration at times of highest expectations.
Slightly fewer than 1 in 4 patients voids 6 unformed stools
per day. The proportion of patients with classic traveler’s di-
arrhea is !40% at intermediate-risk destinations, but clearly is
155% at typical high-risk destinations [3].
Traveler’s diarrhea is hardly life threatening, although a few
fatalities have been reported anecdotally [32]. More important
is the incapacitation due to traveler’s diarrhea. As demonstrated
in table 2, approximately one-third of all patients are unable to
pursue planned activities, which means that, at such typical high-
risk destinations as India or Kenya, 30% and 20%, respectively,
of all travelers are incapacitated. The duration of incapacitation
is half to a full day, which is considerable, particularly if we
assume that many trips last for 1 week only. Additional time is
lost when health professionals need to be consulted.
CHRONOLOGY OF TRAVELER’S DIARRHEA
Traveler’s diarrhea usually occurs during the first week of travel
abroad. Although there is still a risk of illness occurring in
subsequent weeks and for up to 2 years even after episodes of
traveler’s diarrhea [21, 33], it appears that some immunity is
gradually developed [34]. The average duration of untreated
traveler’s diarrhea is ∼4 days; 50% of patients who experience
traveler’s diarrhea are free of symptoms within 48 h [4, 5].
Patients with fever or other symptoms suggestive of severe trav-
eler’s diarrhea and patients in whom pathogens are identified
tend to have a longer duration of illness [35].
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There is a growing interest in sequelae associated with trav-
eler’s diarrhea [36–38]. Early studies have already indicated that
traveler’s diarrhea persists in 1% of patients for 4 months
[39]. According to a recent study, 10% of patients who have
had traveler’s diarrhea thereafter experience irritable bowel syn-
drome [40]. In addition, it has been suggested that inflam-
matory bowel syndrome, which is uncommon in most popu-
lations indigenous to tropical countries, may present for the
first time after a trip to the tropics [41].
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